A patient on lamotrigine 200 mg daily, bupropion extended‑release (Wellbutrin XL) 300 mg daily, and buspirone 15 mg twice daily reports irritability. What are the likely contributors and how should the medication regimen be adjusted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medication Regimen Assessment and Management of Irritability

The irritability is most likely attributable to bupropion (Wellbutrin XL 300 mg), and the first-line intervention should be to reduce the bupropion dose or discontinue it entirely, particularly given the patient is already on lamotrigine for mood stabilization.

Primary Contributors to Irritability

Bupropion as the Likely Culprit

Bupropion is well-documented to cause irritability, agitation, and hostility as neuropsychiatric side effects 1, 2. The FDA drug label explicitly warns that irritability is among the symptoms that "have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications" 2. At the current dose of 300 mg daily, the patient is at the maximum FDA-approved dose, which increases the risk of activating and anxiogenic effects 3.

Critical consideration: Bupropion's activating properties can provoke anxiety and irritability, particularly at higher doses 4. While some studies suggest bupropion may reduce anxiety in depressed patients, its stimulating dopaminergic and noradrenergic effects can also trigger irritability 3, 4.

Lamotrigine's Role

Lamotrigine 200 mg is within therapeutic range and is generally well-tolerated for mood stabilization 5. However, irritability can paradoxically emerge when patients face psychosocial stressors during recovery from mood episodes 6. The guideline emphasizes distinguishing whether irritability stems from the underlying mood disorder versus medication side effects or environmental challenges 6.

Buspirone Contribution

Buspirone 15 mg twice daily (30 mg total) is at the lower end of the therapeutic range (maximum 60 mg/day) 3. Buspirone typically takes 2-4 weeks to become effective and is generally not associated with causing irritability 3, 7. In fact, buspirone augmentation has shown efficacy in reducing anxiety symptoms when added to antidepressants 8.

Recommended Management Algorithm

Step 1: Reassess the Clinical Picture

Before making medication changes, determine:

  • Timing: When did irritability begin relative to medication initiation or dose changes?
  • Pattern: Is irritability constant or does it peak at certain times (suggesting medication peak effects)?
  • Context: Are there concurrent psychosocial stressors that could be contributing? 6
  • Comorbid symptoms: Is there associated anxiety, agitation, insomnia, or mood instability?

Step 2: Modify Bupropion

Primary recommendation:

  • Reduce bupropion to 150 mg daily and monitor for 2-3 weeks, or
  • Discontinue bupropion entirely if irritability is severe

Rationale: The FDA label notes that bupropion "should not be used in agitated patients" 3, and clinical experience shows that doses exceeding certain thresholds increase risk of activation and irritability 9, 10. Since the patient is already on lamotrigine for mood stabilization, the antidepressant burden from bupropion may be excessive.

Step 3: Optimize Existing Medications

If irritability persists after bupropion adjustment:

  • Maintain lamotrigine 200 mg: This is an appropriate dose for mood stabilization and affective instability 5
  • Consider increasing buspirone: Can titrate up to 15 mg three times daily (45-60 mg total) if anxiety is prominent 3, 7

Step 4: Consider Alternative Strategies

If irritability continues despite bupropion reduction:

  • Switch to an SSRI: Agents like escitalopram or sertraline have lower risk of activation and may be better tolerated 11
  • Augment with buspirone: If switching antidepressants, buspirone augmentation has demonstrated efficacy for treatment-resistant depression with 59-63% response rates 8

Critical Warnings and Monitoring

Avoid Polypharmacy Pitfalls

The guideline strongly cautions against using medications to address "all" symptoms without considering psychosocial interventions 6. Irritability related to psychosocial challenges may respond better to therapy than medication adjustments 6.

Monitor for Serious Neuropsychiatric Effects

Bupropion carries warnings for:

  • Worsening depression and suicidality 1, 2
  • Psychosis and mania (particularly at doses >450 mg/day, though can occur at therapeutic doses) 10, 12
  • Seizure risk (dose-dependent, increases significantly above 450 mg/day) 2

Daily monitoring by caregivers is recommended during dose adjustments for emergence of agitation, hostility, or mood changes 2.

Drug Interactions

Be aware that buspirone levels can be significantly increased by CYP3A4 inhibitors (up to 20-fold with some agents), potentially causing increased side effects 7. However, at current dosing, this is unlikely to be contributing to irritability.

Practical Implementation

Immediate action:

  1. Reduce bupropion XL to 150 mg daily (or discontinue if irritability is severe)
  2. Continue lamotrigine 200 mg daily unchanged
  3. Continue buspirone 15 mg twice daily unchanged initially
  4. Schedule follow-up in 2-3 weeks to reassess

If inadequate response at 2-3 weeks:

  1. Consider discontinuing bupropion entirely
  2. Increase buspirone to 15 mg three times daily if anxiety is prominent
  3. Consider adding psychotherapy if not already in place 6

The key principle: Avoid the temptation to add more medications before adequately addressing the most likely culprit—bupropion's activating effects 6, 3.

Related Questions

Can bupropion (Wellbutrin) cause intrusive thoughts in a patient with bipolar disorder?
Does bupropion (Wellbutrin) cause racing thoughts, rumination, or regret loops, or could these symptoms represent hypomania in a chronic overthinker who has been unemployed and socially isolated for the past five years?
Is it appropriate to start Buspirone (Buspar) together with bupropion (Wellbutrin) in a patient who requires both anxiolytic and antidepressant therapy, and what dosing and monitoring should be used?
A 36-year-old woman with ADHD and depression who is taking bupropion (Wellbutrin XL) 300 mg daily presents with new onset irritability; what is the appropriate management?
How should increased anger or irritability be managed in a patient taking Wellbutrin (bupropion)?
What is the recommended antibiotic regimen and dosing for a 4‑month‑old infant with bacterial meningitis?
What is the anion gap for a patient with serum sodium 135 mEq/L, serum chloride 96 mEq/L, serum potassium 3.0 mEq/L, and serum bicarbonate 20 mEq/L?
Does a healthy 9‑month‑old infant require daytime naps?
Why does insulin deficiency in diabetes mellitus not lead to decreased cholesterol synthesis despite the expected down‑regulation, given that increased acetyl‑CoA promotes up‑regulation?
In a 4‑month‑old infant being treated for presumed meningitis with intravenous ampicillin and cefotaxime, who is clinically improving, blood cultures are negative, vital signs are stable, afebrile since day 2, and on day 9 there is no peripheral IV access despite multiple attempts, should the antibiotics be switched to intramuscular administration to complete the 10‑day course, or should IV therapy be continued (e.g., via a PICC line)?
When should one versus two double‑strength tablets of sulfamethoxazole/trimethoprim be used for abdominal wall cellulitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.